Quality of Life with 24-hour Subcutaneous Levodopa/Carbidopa Infusion (ND0612): QoL Results from a Phase 3 Randomized, Active-controlled Study (P11-5.007)
Year: 2025
Type: article
Source: Neurology
Authors: Harini Sarva, Michele Tagliati, Werner Poewe, Fabrizio Stocchi, Olivier Rascol, Tami Yardeni, Nelson Lopes, Jonathan Pereira, Alberto Espay
Institutions: Weill Cornell Medical Center, Cedars-Sinai Medical Center, Innsbruck Medical University, Universität Innsbruck, Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele, Inserm, French Clinical Research Infrastructure Network, Centre d’Investigation Clinique 1436, Université de Toulouse, Tanabe Pharma Corporation (Japan), University of Cincinnati
Language: English
Subfield: Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4409227195